Back
Oramed Pharmaceuticals 10K Form
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.33
Seasonality Move:
22.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
| 2023-11-09 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
| 2023-08-10 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
| 2023-05-11 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
| 2022-11-10 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
| 2022-08-10 | 10Q | ORMP/Oramed Pharmaceuticals Quarterly |
Receive ORMP News And Ratings
See the #1 stock for the next 7 days that we like better than ORMP
ORMP Financial Statistics
Sales & Book Value
| Annual Sales: | $1.34M |
|---|---|
| Cash Flow: | $2.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.36 |
| Price / Book: | 0.54 |
Profitability
| EPS (TTM): | 0.51000 |
|---|---|
| Net Income (TTM): | $20.86M |
| Gross Margin: | $2.71M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Oramed Pharmaceuticals Earnings Forecast
Key Oramed Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 15 years for ORMP is 299.78%.
- The Selling, General & Administrative Expenses for ORMP have been equal to 607.31% of Gross Profit Margin.
- The Research & Development expenses have been 669.48% of Revenue.
- The Interest Expense is 36.87% of Operating Income.
- The Net Earning history of ORMP is 412.31% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 7 years.
Oramed Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ORMP |
| CUSIP: | 68403P |
| Website: | oramed.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.71 |
|---|---|
| Forward P/E Ratio: | 0 |
ORMP Technical Analysis vs Fundamental Analysis
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a Sell
The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.